A Phase 1, First in Human Study to Investigate the Safety and Tolerability of PA401

NCT01627002 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

BIOLOGICAL: PA401
OTHER: Placebo

Sponsor

ProtAffin Biotechnologie AG